Legendary supermodels Adriana Lima, Alessandra Ambrosio, Tyra Banks and more made their grand return to the Victoria’s Secret Fashion Show on Tuesday. Take a trip down memory lane and revisit ...
The percentage of patients with very good or good compliance with medication was similar (p = 0.08) between the Gaviscon® (95.7%) and omeprazole (95.9%) groups. By D7, overall self-assessed ...
Arsenal have begun life without Jonas Eidevall with victory over Valerenga in the Women’s Champions League. Last week’s 5-2 loss against Bayern Munich left interim boss Renee Slegers needing ...
Around £2billion was added to the value of GSK after the pharmaceuticals giant agreed a £1.7billion settlement over claims that its heartburn medicine Zantac caused cancer. Shares rose 3.2 per ...
GSK agreed to pay $2.2 billion to settle approximately 80,000 lawsuits in U.S. courts over claims its heartburn drug, Zantac, caused cancer. The settlements account for 93% of all cases and were ...
UK pharmaceutical giant, GSK said it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.
The UK based drug firm GSK has agreed to pay up to $2.2bn (£1.7bn; €2bn) to settle claims that the heartburn drug ranitidine (previously marketed in the US as Zantac) caused cancer. The deal, ...
However the pharmaceutical giant said it has not admitted any liability by settling the case as the scientific consensus remains that there is no consistent or reliable evidence that ranitidine is ...
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.
GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...
作为协议的一部分,葛兰素史克不承认存在不当行为,并在一份声明中表示,“没有一致或可靠的证据”表明该药的活性成分雷尼替丁(ranitidine ...
The discontinued version of the drug, Zantac, had triggered 80,000 lawsuits from 10 different law firms in the US and has hung over the FTSE 100 drugmaker in recent months. However, the settlement ...